Start-Up Spotlight: NovaSignal Aims To Commercialize Transcranial Ultrasound
With a mostly forgotten imaging modality, NovaSignal is trying to create the “fifth vital sign.” Medtech Insight spoke to chairman and chief executive officer, Diane Bryant, to learn more about the company's transcranial ultrasound technology.
You may also be interested in...
As the SPAC boom continues, innovative medtechs are expected to become acquisition targets.
Babson recently raised $31m to accelerate commercialization of its blood testing “ecosystem,” developed with help from Siemens Healthineers and Becton Dickinson.
MeMed’s test measures immune system response to assess a patient’s COVID-19 trajectory.